Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
06/1998
06/04/1998WO1998023170A1 Process for obtaining plant peptones with a high hydrolysis degree and applications thereof
06/04/1998WO1998023155A1 Arthropodicidal and fungicidal cyclic amides
06/04/1998WO1998023151A1 Use of thrombolytic reagents for prevention of vascular disease
06/04/1998WO1998013493A3 A family of genes encoding apoptosis-related peptides, peptides encoded thereby and methods of use thereof
06/04/1998WO1998011238A3 Protease m, a novel serine protease
06/04/1998WO1998000171A3 Conjugates of thrombin inhibitors and endogenes carriers
06/04/1998DE19649266A1 The new peptide lipohexin
06/04/1998DE19649233A1 Nucleic acid encoding interleukin-16 polypeptide
06/04/1998CA2274313A1 Mammalian chemokines
06/04/1998CA2274143A1 Murine guanine nucleotide exchange factor - (mngef) and human homologues thereof
06/04/1998CA2272992A1 Synthetic glycoamines, methods for their use that affect cell
06/04/1998CA2272987A1 Novel gene encoding male-transplantation antigen
06/04/1998CA2272900A1 Agent and method of treatment for diseases and conditions associated with respiratory ailments and lung inflammation
06/04/1998CA2272846A1 Processed polypeptides with il-16 activity, processes for their production and their use
06/04/1998CA2272637A1 Transfecting composition usable in gene therapy combining a recombinant virus incorporating an exogenous nucleic acid, a non-viral and non-plasmid transfecting agent
06/04/1998CA2272603A1 Multimeric erythropoietin with increased biological activity
06/04/1998CA2272536A1 Immune responses using compositions containing stress proteins
06/04/1998CA2272345A1 Bmp-4 promoter and use thereof in screening of therapeutic agents for the prevention and/or treatment of osteoporosis
06/04/1998CA2272243A1 Novel low density lipoprotein binding proteins and their use in diagnosing and treating atherosclerosis
06/04/1998CA2272239A1 Fibroblast growth factor-13
06/04/1998CA2271953A1 A novel cloned gaba-receptor subunit cdna sequence and stably co-transfected cell lines
06/04/1998CA2270283A1 Human sqm1 protein homolog comprising a cell adhesion protein
06/04/1998CA2243944A1 Phosphatidylinositol 3-kinase p110 delta catalytic subunit
06/03/1998EP0845539A1 Isolation and purification of tetrahydropyrimidine derivatives
06/03/1998EP0845537A1 Recombinant retroviruses delivering vector constructs to target cells
06/03/1998EP0845535A2 Leader peptidase (lep) from Streptococcus
06/03/1998EP0845531A2 Polypeptides and polynucleotides from the Staphylococcus SigB operon
06/03/1998EP0845530A2 Interferon gamma inducing factor
06/03/1998EP0845529A2 Human G-protein coupled receptor protein cloned form fetal brain CDNA library
06/03/1998EP0845478A1 Reductive alkylation of glycopeptide antibiotics
06/03/1998EP0845475A1 Inositolglycans with insular activity
06/03/1998EP0845269A2 Liposomal human calcitonin gene-related peptide composition and preparation of the same
06/03/1998EP0845268A2 Composition for treating cornea
06/03/1998EP0845267A1 Neurotoxin for cutaneous disorders in mammals
06/03/1998EP0845266A2 Sweet whey concentrate containing antioxidant compositions
06/03/1998EP0845265A1 Mucosal preparation containing physiologically active peptide
06/03/1998EP0845045A1 Regulation of cellular functions by ectopic expression of non-endogenous cell signalling receptors
06/03/1998EP0845039A2 Genes and proteins controlling cholesterol synthesis
06/03/1998EP0845036A1 Functional role of adrenomedullin (am) and the gene-related product (pamp) in human pathology and physiology
06/03/1998EP0845035A2 Urocortin peptides
06/03/1998EP0845034A1 Nucleic acid molecules encoding peptides having pronociceptive properties
06/03/1998EP0845033A1 Aortic preferentially-expressed gene apeg-1 and uses thereof
06/03/1998EP0845032A2 Isolated nucleic acid molecules, peptides which form complexes with mhc molecule hla-a2 and uses thereof
06/03/1998EP0845007A2 Pharmaceutical composition containing inhibitors of interferon-gamma
06/03/1998EP0845006A2 Binding of osteogenic protein-i (op-1) and analogs thereof to the cell surface receptor alk-1 and analogs thereof
06/03/1998EP0845005A1 Traf inhibitors
06/03/1998EP0845003A1 Novel opioid peptides
06/03/1998EP0845002A2 Amino acid amides of 5-amino-1,3,4-thiadiazones and their use as inhibitors for matrix metalloproteinases
06/03/1998EP0844885A2 Chemical compounds
06/03/1998EP0844884A2 Endothelin antagonists and endothelin synthase inhibitors for the prevention and treatment of uterine contractility disorders, preeclampsia, atherosclerotic vascular disease, hypertension and for hormone replacement therapy
06/03/1998EP0844883A1 Use of conotoxin peptides u002 and mii for treating or detecting small-cell lung carcinoma
06/03/1998EP0844882A1 Appetite regulating compositions
06/03/1998EP0844874A1 METHODS AND COMPOSITIONS USEFUL FOR INHIBITION OF $g(a) v?$g(b) 5? MEDIATED ANGIOGENESIS
06/03/1998EP0833834A4 Dna sequence and encoded mammary-specific breast cancer protein
06/03/1998EP0509984B1 Method of preparing lysozyme dimers
06/03/1998CN1183807A Human chemokine beta-13
06/03/1998CN1183805A Chemokine receptos 88-2B £CKR-3| and 88C and their antibodies
06/03/1998CN1183786A Bicyclic tachykinins antagonists, preparation thereof and their use in autagonistes composition
06/03/1998CN1183785A Novel peptides and remedy for bone diseases contg. same as active ingredient
06/03/1998CN1183784A Peptides and remedy for autoimmune diseases comprising same
06/03/1998CN1183727A Method of preventing TPO adsorption and stable TPO-contg. composition
06/03/1998CN1183725A Pineal gland specific gene-1
06/03/1998CN1183722A Use of penciclovir for treatment of human herpes-virus-8
06/03/1998CN1183720A Method for treatment of macular degeneration
06/02/1998US5760285 Phosphonyldipeptides useful in the treatment of cardiovascular diseases
06/02/1998US5760235 Anticoagulant peptide derivatives and pharmaceutical compositions containing the same as well as a process for preparation thereof
06/02/1998US5760205 Isolated nucleotide sequences corresponding to mitochondrial cytochrome oxidase genes
06/02/1998US5760204 Cdna sequence codes for autoimmune disorders and diseases with eosinophilia
06/02/1998US5760203 Gap gene sequences
06/02/1998US5760187 Selectively adsorbing human growth hormone in solution onto blue pigment-bonded carrier, eluting
06/02/1998US5760186 Inflammatory cytokine, diagnosis and therapy
06/02/1998US5760185 Anti-feline herpes virus-1 recombinant antibody and gene fragment coding for said antibody
06/02/1998US5760180 Kits and dna(cdna) codes and cloning expression vectors
06/02/1998US5760178 Antitumor
06/02/1998US5760177 Lipopolysaccharide binding protein and process for producing the same
06/02/1998US5760072 Paclitaxel prodrugs, method for preparation as well as their use in selective chemotherapy
06/02/1998US5760047 Method for treatment of obesity using prolactin modulators and diet
06/02/1998US5760026 Administering lysostaphin
06/02/1998US5760024 Using cyclooxygenase inhibitors such as aspirin to promote embryo implantation
06/02/1998US5760015 Cyclodextrin compounds and methods of making and use thereof
06/02/1998US5760012 Genetic engineered nucleotide for treating genetic disorders
06/02/1998US5760003 Hemoregulatory peptides
06/02/1998US5760002 Analgesics
06/02/1998US5760001 Cytokine restraining agents and methods of use in pathologies and conditions associated with altered cytokine levels
06/02/1998US5760000 Administering a polypeptide
06/02/1998US5759999 Platelet aggregation inhibitors
06/02/1998US5759997 Carrier mixture of ethoxylated, hydrogenated castor oil andglycerides
06/02/1998US5759996 Reduce bone resorption, angiogenesis, and restenosis
06/02/1998US5759995 Administering cyclomarin a to treat herpes virus infections
06/02/1998US5759994 Antithrombin peptide for cardiovascular disorders
06/02/1998US5759993 Modified sialyl Lewisx compounds
06/02/1998US5759992 Immunotherapeutic agent derived from bacteria and method for its manufacture
06/02/1998US5759991 Neurotrophic peptide derivatives
06/02/1998US5759863 Binding immune complexes or aggregated immunoglobulin with a gene expressed polypeptide or oligopeptide
06/02/1998US5759854 Protein
06/02/1998US5759852 Expression vector containing PL6M promoter and TAT32 ribosome binding site and host cells transformed therewith
06/02/1998US5759832 Polypeptides; fatty acid biosynthesis
06/02/1998US5759818 N-terminal CTP extended pharmaceutical peptides and proteins
06/02/1998US5759813 Methods and compositions relating to useful antigens of moraxella catarrhalis
06/02/1998US5759812 Human selenium-binding protein
1 ... 2620 2621 2622 2623 2624 2625 2626 2627 2628 2629 2630 2631 2632 2633 2634 2635 2636 2637 2638 2639 2640 ... 3163